Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

DIASYS DIAGNOSTIC SYSTEMS

Develops, manufactures, and distributes diagnostic systems for clinical chemistry and immunoturbidimetry. Supplies hi... read more Featured Products: More products

Download Mobile App




Photometric Tests for Common Electrolytes Provide High-Precision Alternative

By LabMedica International staff writers
Posted on 19 Mar 2014
As a high quality, reliable alternative or compliment to ion-selective electrode (ISE)-based diagnosis, new photometric tests for sodium, potassium, and chloride provide accurate and precise results over a wide linear range, and are applicable to almost any clinical chemistry analyzer. More...


Liquid-stable, ready-to-use reagents for photometric determination of sodium, potassium, and chloride are now available from DiaSys Diagnostic Systems (Holzheim, Germany). The drawback of the ISE-based method is the high price for labs with a small to mid-size amount of measurement requests. Time-consuming rinsing and renewal of expensive electrodes regardless of number of tests performed, result in high regular maintenance costs. Using its leading technology in fluid-stable reagents, DiaSys has developed these high-precision photometric electrolyte tests as the laborsaving and economic alternative. In addition, no separate dedicated workstation is required.

Additional advantages of the tests include: minimized interferences, traceable to international reference material, excellent on-board and calibration stability, long shelf-life of reagents, reduced workload for lab staff, no sample splitting needed, one report per patient, improved traceability of patient results, reduced risk of data transfer errors. Measuring ranges are: Sodium FS [Fluid Stable] = 100–180 mmol/L, Potassium FS = 2–8 mmol/L, Chloride 21 FS = 40–170 mmol/L

The innovative testing system also includes a one-for-all multielectrolyte calibrator, TruCal E, a liquid-stable, ready-to-use (no dilution steps) calibrator for sodium, potassium, chloride, that contains serum to react more like patient samples. The photometric tests can also be used as a simple backup for ISE-based analysis.

Processes and resources are certified according to ISO 13485, ISO 9001, and fulfill highest internal quality standards. Sustainable processes and products preserve the environment. The chloride test uses an innovative methodology avoiding toxic and harming mercury compounds used in established reagents. Premium after-sales service is also provided.

Related Links:

DiaSys Diagnostic Systems



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.